| |
| |
|
| Insider
Information: |
Angotti Vincent J. |
| Relationship: |
|
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
170,806 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$175,930 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
170,806 |
|
|
| Total
Value |
$175,930 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 17.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acelrx Pharmaceuticals Inc |
ACRX |
|
2024-03-12 |
170,806 |
2017-08-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-08-24 |
4 |
B |
$3.00 |
$45,000 |
D/D |
15,000 |
15,000 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-08-07 |
4 |
B |
$2.90 |
$28,950 |
D/D |
10,000 |
35,000 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-08-31 |
4 |
A |
$1.49 |
$9,000 |
D/D |
6,040 |
41,040 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
D |
$2.02 |
$4,004 |
D/D |
(1,982) |
49,360 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-12-12 |
4 |
B |
$2.99 |
$29,890 |
D/D |
10,000 |
51,040 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-12-14 |
4 |
B |
$2.78 |
$10,024 |
D/D |
3,610 |
54,650 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-03-03 |
4 |
D |
$1.31 |
$2,231 |
D/D |
(1,703) |
63,836 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-02-11 |
4 |
D |
$1.68 |
$5,579 |
D/D |
(3,321) |
65,539 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
68,860 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-09-11 |
4 |
B |
$0.80 |
$7,950 |
D/D |
10,000 |
91,805 |
2.81 |
% |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-02-11 |
4 |
D |
$1.10 |
$4,095 |
D/D |
(3,723) |
94,762 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-02-10 |
4 |
D |
$1.10 |
$3,652 |
D/D |
(3,320) |
98,485 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-12-13 |
4 |
B |
$0.73 |
$7,268 |
D/D |
10,000 |
101,805 |
2.81 |
% |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
58,667 |
153,429 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-03-03 |
4 |
D |
$1.30 |
$2,110 |
D/D |
(1,623) |
161,806 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-11 |
4 |
A |
$1.12 |
$1,115 |
D/D |
1,000 |
162,806 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-12 |
4 |
A |
$1.12 |
$8,995 |
D/D |
8,000 |
170,806 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
254,650 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-02-28 |
4 |
B |
$2.81 |
$9,088 |
D/D |
3,234 |
257,884 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-06-05 |
4 |
B |
$2.31 |
$11,550 |
D/D |
5,000 |
262,884 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-11-11 |
4 |
B |
$1.79 |
$14,973 |
D/D |
8,379 |
275,944 |
2.81 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-11 |
4 |
D |
$2.63 |
$60,627 |
D/D |
(23,052) |
427,887 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-06 |
4 |
D |
$2.59 |
$64,903 |
D/D |
(25,059) |
450,939 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-11 |
4 |
D |
$1.71 |
$39,419 |
D/D |
(23,052) |
452,892 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-06-15 |
4 |
B |
$1.33 |
$10,035 |
D/D |
7,547 |
468,757 |
2.81 |
% |
|
32 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
